Jy-xhe-053, a benzodiazepine ligand less efficacious at GABAA receptors containing alpha1 and alpha5 than alpha2 and alpha3 subunits
Authorized Users Only
2009
Authors
Milinković, Marija M.Savić, Miroslav

Huang, Shengming
Furtmueller, Roman
Majumder, Samarpan
Samardžić, Janko

Divljaković, Jovana
Roth, Brian L.
Sieghart, Werner

Cook, James M.

Conference object (Published version)

Metadata
Show full item recordSource:
European Neuropsychopharmacology, 2009, 19, Supplement 3, S296-S296Publisher:
- Elsevier Science BV, Amsterdam
Note:
- 22nd ECNP Congress 12-16 September 2009 • Istanbul, Turkey
- Basic and clinical neuroscience – Animal behaviour
Collections
Institution/Community
PharmacyTY - CONF AU - Milinković, Marija M. AU - Savić, Miroslav AU - Huang, Shengming AU - Furtmueller, Roman AU - Majumder, Samarpan AU - Samardžić, Janko AU - Divljaković, Jovana AU - Roth, Brian L. AU - Sieghart, Werner AU - Cook, James M. PY - 2009 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1173 PB - Elsevier Science BV, Amsterdam C3 - European Neuropsychopharmacology T1 - Jy-xhe-053, a benzodiazepine ligand less efficacious at GABAA receptors containing alpha1 and alpha5 than alpha2 and alpha3 subunits VL - 19 IS - Supplement 3 SP - S296 EP - S296 DO - 10.1016/S0924-977X(09)70438-9 ER -
@conference{ author = "Milinković, Marija M. and Savić, Miroslav and Huang, Shengming and Furtmueller, Roman and Majumder, Samarpan and Samardžić, Janko and Divljaković, Jovana and Roth, Brian L. and Sieghart, Werner and Cook, James M.", year = "2009", publisher = "Elsevier Science BV, Amsterdam", journal = "European Neuropsychopharmacology", title = "Jy-xhe-053, a benzodiazepine ligand less efficacious at GABAA receptors containing alpha1 and alpha5 than alpha2 and alpha3 subunits", volume = "19", number = "Supplement 3", pages = "S296-S296", doi = "10.1016/S0924-977X(09)70438-9" }
Milinković, M. M., Savić, M., Huang, S., Furtmueller, R., Majumder, S., Samardžić, J., Divljaković, J., Roth, B. L., Sieghart, W.,& Cook, J. M.. (2009). Jy-xhe-053, a benzodiazepine ligand less efficacious at GABAA receptors containing alpha1 and alpha5 than alpha2 and alpha3 subunits. in European Neuropsychopharmacology Elsevier Science BV, Amsterdam., 19(Supplement 3), S296-S296. https://doi.org/10.1016/S0924-977X(09)70438-9
Milinković MM, Savić M, Huang S, Furtmueller R, Majumder S, Samardžić J, Divljaković J, Roth BL, Sieghart W, Cook JM. Jy-xhe-053, a benzodiazepine ligand less efficacious at GABAA receptors containing alpha1 and alpha5 than alpha2 and alpha3 subunits. in European Neuropsychopharmacology. 2009;19(Supplement 3):S296-S296. doi:10.1016/S0924-977X(09)70438-9 .
Milinković, Marija M., Savić, Miroslav, Huang, Shengming, Furtmueller, Roman, Majumder, Samarpan, Samardžić, Janko, Divljaković, Jovana, Roth, Brian L., Sieghart, Werner, Cook, James M., "Jy-xhe-053, a benzodiazepine ligand less efficacious at GABAA receptors containing alpha1 and alpha5 than alpha2 and alpha3 subunits" in European Neuropsychopharmacology, 19, no. Supplement 3 (2009):S296-S296, https://doi.org/10.1016/S0924-977X(09)70438-9 . .